BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 4433389)

  • 1. [Importance of heparin in infants with consumption coagulation disease caused by septicemia].
    de Aquino-Jaso ME; Olvera-Hidalgo C; Ramírez JI
    Bol Med Hosp Infant Mex; 1974; 31(1):73-84. PubMed ID: 4433389
    [No Abstract]   [Full Text] [Related]  

  • 2. Early heparin therapy in 60 children with acute meningococcemia. Relationship between clinical manifestations and coagulation abnormalities.
    Blum D; Fondu P; Denolin-Reubens R; Dubois J
    Acta Chir Belg; 1973 Jul; 72(4):288-97. PubMed ID: 4766888
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin therapy in septicemia with disseminated intravascular coagulation.
    Corrigan JJ; Jordan CM
    N Engl J Med; 1970 Oct; 283(15):778-82. PubMed ID: 4989565
    [No Abstract]   [Full Text] [Related]  

  • 4. [Heparin therapy in meningococcal sepsis].
    Masera G; Carnelli V
    Minerva Pediatr; 1969 Feb; 21(8):321. PubMed ID: 5795994
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin therapy in meningococcal thrombocytopenic coagulopathy.
    Pierce LE; Cutler LD; Curtin JA
    Med Ann Dist Columbia; 1971 Jan; 40(1):19-22. PubMed ID: 5276267
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic widespread intravascular coagulation syndrome and cyanotic congenital cardiopathy. The place of heparin during preoperative period].
    Baille Y; Blanc T; Monties JR; Goudard A; Henry E
    Presse Med (1893); 1970 Aug; 78(36):1571-4. PubMed ID: 5456287
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the effect of various antifibrinolytic agents on blood coagulation].
    Gerl D; Bonow A
    Med Klin; 1969 Feb; 64(9):374-8. PubMed ID: 5783025
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thromboembolic disease of long standing with hyperfibrinogenemia. Treatment with heparin, magnesium and anti-inflammatory agent].
    Cristau P; Hainaut J; Molinie C; Essioux H; Pariente A; Florent C; Laverdant C
    Ann Med Interne (Paris); 1977 Nov; 128(11):887-94. PubMed ID: 563206
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with Calciparin, a new subcutaneously injectable heparin preparation].
    Sessner HH; Brockhaus W; Kunzmann G; Stingl J
    Med Welt; 1971 Jan; 5():187-91. PubMed ID: 5546024
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects and therapy of consumption coagulopathy].
    Lechner K
    Munch Med Wochenschr; 1971 Jun; 113(25):969-70. PubMed ID: 5108723
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination of heparin and dipyridamol (persantin) in the treatment of various coagulation disorders in infants].
    Prişcu R; Maiorescu M; Manolescu E; Anca I; Coeugniet E
    Rev Pediatr Obstet Ginecol Pediatr; 1974; 23(4):339-45. PubMed ID: 4219648
    [No Abstract]   [Full Text] [Related]  

  • 12. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
    Raby C
    Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
    [No Abstract]   [Full Text] [Related]  

  • 13. [The influence of heparin on the acute consumption coagulopathy and the subsequent hypercoagulability of the blood. A study by animal experiment].
    Vinazzer H
    Thromb Diath Haemorrh; 1968 Mar; 19(1):255-66. PubMed ID: 5652233
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences with anticoagulant therapy in children with consumption coagulopathies].
    Lo SS; Frick PG; Straub PW; Hitzig WH
    Bibl Haematol; 1969; 32():298-304. PubMed ID: 5387513
    [No Abstract]   [Full Text] [Related]  

  • 15. [Control of blood coagulation in extracorporeal circulation].
    Neef H
    Med Klin; 1971 Jan; 66(1):16-21. PubMed ID: 5545364
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathogenetic therapy of the hemostatic disorders in suppurative and septic diseases of the newborn].
    Shilenko VI; Samsygina GA; Vykhristiuk OF; Tsybul'skaia GV
    Pediatriia; 1980 Jun; (6):57-61. PubMed ID: 7402841
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravascular coagulation in Gram-negative septicaemia.
    Kimber RJ
    Br J Urol; 1970 Dec; 42(6):741. PubMed ID: 5491933
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemocoagulative response to K antivitaminics after 48 hours of treatment].
    Navarro Bort P; Llopis Guarner R; Giménez Lorente JV; Tormo Alfonso V
    Rev Clin Esp; 1974 Sep; 134(5):461-6. PubMed ID: 4438741
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental meningococcal septicemia. Effect of heparin therapy.
    Gaskins RA; Dalldorf FG
    Arch Pathol Lab Med; 1976 Jun; 100(6):318-24. PubMed ID: 946760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modifications of coagulation after in-vivo meutralization of endogenous heparine liberated in dogs after injection of incompatible red blood cells].
    Dosne AM
    C R Seances Soc Biol Fil; 1971; 165(1):52-5. PubMed ID: 4257751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.